MALVERN, Pa., July 12, 2024 /CNW/ -- Endo, Inc. (OTCQX: NDOI) ("Endo" or the "Company"), a diversified specialty pharmaceutical company transforming insights into life-enhancing therapies, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results